Insider · CIK 0002131255
Mark Fennell
Files at CGNX (COGNEX CORP). First filing May 12, 2026, latest May 12, 2026.
In brief
Mark Fennell files SEC Form 4 as officer at CGNX (COGNEX CORP). Since May 12, 2026, Mark Fennell has reported 0 open-market buys worth $0 and 1 open-market sell worth $4.3M, the latest filed on May 12, 2026.
A track record needs three past buys with six months of prices behind them; Mark Fennell has 0, so none is measured yet.
The newest scored trade: sold $4.3M of CGNX on May 11, 2026, filed May 12, 2026, scored 53 (moderate). In the last 12 months: 0 buys worth $0 and 1 sell worth $4.3M.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CGNX: COGNEX CORP
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 53Moderate | COGNEX CORP | $4.3M 64,873 shares | -576% | +128% from low0% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| May 11, 2026 | CGNX COGNEX CORPORATION | 64,873 0.04% of outstanding | $4.4M | May 11, 2026 | none |
Transactions
Every row this insider has filed, 26 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 11, 2026 | CGNX COGNEX CORP | MOption exercise Common Stock | +6,400 | $51.49 | $330k | 11,263 | May 12, 2026 |
| May 11, 2026 | CGNX COGNEX CORP | SOpen-market sale Common Stock | -6,400 | $67.08 | $429k | 4,863 | May 12, 2026 |
| May 11, 2026 | CGNX COGNEX CORP | MOption exercise Common Stock | +18,296 | $47.21 | $864k | 23,159 | May 12, 2026 |
| May 11, 2026 | CGNX COGNEX CORP | SOpen-market sale Common Stock | -18,296 | $67.08 | $1.2M | 4,863 | May 12, 2026 |
| May 11, 2026 | CGNX COGNEX CORP | MOption exercise Common Stock | +15,080 | $39.44 | $595k | 19,943 | May 12, 2026 |
| May 11, 2026 | CGNX COGNEX CORP | SOpen-market sale Common Stock | -15,080 | $67.08 | $1.0M | 4,863 | May 12, 2026 |
| May 11, 2026 | CGNX COGNEX CORP | MOption exercise Common Stock | +6,634 | $33.04 | $219k | 11,497 | May 12, 2026 |
| May 11, 2026 | CGNX COGNEX CORP | SOpen-market sale Common Stock | -6,634 | $67.08 | $445k | 4,863 | May 12, 2026 |
| May 11, 2026 | CGNX COGNEX CORP | MOption exercise Common Stock | +9,600 | $56.44 | $542k | 14,463 | May 12, 2026 |
| May 11, 2026 | CGNX COGNEX CORP | SOpen-market sale Common Stock | -9,600 | $67.08 | $644k | 4,863 | May 12, 2026 |
| May 11, 2026 | CGNX COGNEX CORP | MOption exercise Common Stock | +4,000 | $42.84 | $171k | 8,863 | May 12, 2026 |
| May 11, 2026 | CGNX COGNEX CORP | SOpen-market sale Common Stock | -4,000 | $67.08 | $268k | 4,863 | May 12, 2026 |
| May 11, 2026 | CGNX COGNEX CORP | SOpen-market sale Common Stock | -4,863 | $66.73 | $325k | 0 | May 12, 2026 |
| May 11, 2026 | CGNX COGNEX CORP | MOption exercise Non-Qualified Stock Option (right to buy)derivative | -6,634 | $0.00 | $0 | 26,534 | May 12, 2026 |
| May 11, 2026 | CGNX COGNEX CORP | MOption exercise Non-Qualified Stock Option (right to buy)derivative | -15,080 | $0.00 | $0 | 22,618 | May 12, 2026 |
| May 11, 2026 | CGNX COGNEX CORP | MOption exercise Non-Qualified Stock Option (right to buy)derivative | -4,000 | $0.00 | $0 | 0 | May 12, 2026 |
| May 11, 2026 | CGNX COGNEX CORP | MOption exercise Non-Qualified Stock Option (right to buy)derivative | -18,296 | $0.00 | $0 | 12,196 | May 12, 2026 |
| May 11, 2026 | CGNX COGNEX CORP | MOption exercise Non-Qualified Stock Option (right to buy)derivative | -6,400 | $0.00 | $0 | 0 | May 12, 2026 |
| May 11, 2026 | CGNX COGNEX CORP | MOption exercise Non-Qualified Stock Option (right to buy)derivative | -9,600 | $0.00 | $0 | 0 | May 12, 2026 |
| Feb 17, 2026 | CGNX COGNEX CORP | AGrant or award Non-Qualified Stock Option (right to buy)derivative | +7,231 | $0.00 | $0 | 7,231 | May 12, 2026 |
| Feb 22, 2022 | CGNX COGNEX CORP | AGrant or award Non-Qualified Stock Option (right to buy)derivative | +22,412 | $0.00 | $0 | 22,412 | May 12, 2026 |
| Feb 22, 2022 | CGNX COGNEX CORP | AGrant or award Non-Qualified Stock Option (right to buy)derivative | +30,464 | $0.00 | $0 | 52,876 | May 12, 2026 |
| Feb 16, 2021 | CGNX COGNEX CORP | AGrant or award Non-Qualified Stock Option (right to buy)derivative | +8,921 | $0.00 | $0 | 8,921 | May 12, 2026 |
| Feb 20, 2024 | CGNX COGNEX CORP | AGrant or award Restricted Stock Unitderivative | +3,169 | $0.00 | $0 | 3,169 | May 12, 2026 |
| Feb 18, 2025 | CGNX COGNEX CORP | AGrant or award Restricted Stock Unitderivative | +9,685 | $0.00 | $0 | 9,685 | May 12, 2026 |
| Feb 17, 2026 | CGNX COGNEX CORP | AGrant or award Restricted Stock Unitderivative | +11,211 | $0.00 | $0 | 11,211 | May 12, 2026 |
Questions about Mark Fennell
Answered from the filings on this page, as of the latest one.
Is Mark Fennell buying or selling?
In the last 12 months Mark Fennell reported 0 open-market buys worth $0 and 1 open-market sell worth $4.3M on SEC Form 4; the latest was sold $4.3M of CGNX on May 11, 2026. Grants, option exercises and tax withholding are not counted.
How did Mark Fennell's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Mark Fennell has 0.
Where does Mark Fennell file Form 4?
Mark Fennell has filed Form 4 at CGNX (COGNEX CORP) as Chief Legal Officer &Secretary. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.